Drug-delivering contact lens for recurrent macular swelling
Treatments studied
Part of Eyes & vision clinical trials.
This study tests a special contact lens that slowly delivers anti-inflammatory/steroid medicine to the back of the eye. It aims to treat cystoid macular edema that keeps coming back and may improve vision for people who respond to steroid treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 18 to 85 and willing to sign consent and follow study visits
- Have cystoid macular edema in the study eye affecting the center of the macula, confirmed by eye scans
- Have certain eye measurements in the study eye: cornea thickness 480–620 µm and enough macular swelling on OCT
- Your vision in the study eye must be between 20/400 and 20/25 using a pinhole test
- Your treatment history must fit Phase A or Phase B (mostly responds only to drops, or only responds only to steroid injections)
- Be able to wear the study contact lens and not have conditions that block contact lens use or eye safety
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a steroid medication can help reduce swelling in the back of the eye caused by diabetic macular edema, a complication of type 2 diabetes. If you qualify, you may receive this treatment to potentially improve your vision.
This trial looks at which long-acting steroid implant works better for diabetic macular swelling that did not improve enough with past treatments. It may help patients by testing a treatment option aimed at improving vision when other eye injections have not worked well.
This study tests combining vitrectomy (surgery to remove the membrane from the retina) with a dexamethasone implant (a tiny steroid that is placed inside the eye to reduce swelling) for people with a specific type of eye membrane and fluid buildup in the center of the retina.
This trial tests whether combining a steroid implant (dexamethasone) with an anti-VEGF injection (aflibercept) works better than the injection alone for people with diabetic macular edema who haven't been treated yet. It aims to improve vision and reduce retinal swelling.
This trial tests whether a single steroid injection around the back of the eye can improve vision in people with diabetic macular edema (swelling in the center of the retina that blurs vision). It is for people who have not yet had any other eye treatments for this condition.
This Phase 4 study looks at a treatment plan around the time of planned surgery on both eyes (called RLE). It may help the researchers learn how safe and effective the approach is for improving eye outcomes after surgery.
Hear when a new Cystoid Macular Edema trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.